Business
BioNTech surges on COVID-19 vaccine sales forecast – The Australian Financial Review
BioNTech and partner Pfizer signed contracts to deliver some 2.2 billion doses of the two-shot vaccine this year and more than…
The technology is also being tested in cancer, in an aim to spur the immune system to fight off tumours. BioNTech has started six new patient trials this year — for a total of 15 experimental drugs in 18 trials — and said it plans to move two more potential…
Continue Reading
-
General15 hours agoMore buses without dedicated lanes likely after Gold Coast light rail plan scrapped
-
Business21 hours agoBuy this monthly high-yield ETF instead
-
Business19 hours agoThis artificial intelligence (AI) stock could be the Nvidia of quantum computing
-
Business19 hours agoTesla just offered Elon Musk $1 trillion. Here’s what it could mean for the company.